Yared Gurmu

1.3k total citations
17 papers, 706 citations indexed

About

Yared Gurmu is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yared Gurmu has authored 17 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yared Gurmu's work include Cardiovascular Function and Risk Factors (5 papers), Heart Failure Treatment and Management (5 papers) and Diabetes Treatment and Management (4 papers). Yared Gurmu is often cited by papers focused on Cardiovascular Function and Risk Factors (5 papers), Heart Failure Treatment and Management (5 papers) and Diabetes Treatment and Management (4 papers). Yared Gurmu collaborates with scholars based in United States, United Kingdom and France. Yared Gurmu's co-authors include Deepak L. Bhatt, Marc S. Sabatine, Eugene Braunwald, Benjamin M. Scirica, David A. Morrow, Ofri Mosenzon, Philippe Gabríel Steg, Anthony Keech, Robert P. Giugliano and Nicholas Marston and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Yared Gurmu

17 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yared Gurmu United States 13 309 213 177 114 92 17 706
Benjamin J. Hirsh United States 13 341 1.1× 264 1.2× 162 0.9× 161 1.4× 82 0.9× 23 764
Mireia Junyent Spain 18 389 1.3× 337 1.6× 229 1.3× 107 0.9× 103 1.1× 37 971
Srikanth Yandrapalli United States 19 611 2.0× 258 1.2× 161 0.9× 96 0.8× 200 2.2× 94 1.0k
Yaping Zhang China 15 210 0.7× 93 0.4× 84 0.5× 142 1.2× 180 2.0× 56 1.2k
James Underberg United States 19 287 0.9× 587 2.8× 264 1.5× 88 0.8× 61 0.7× 55 966
Pin‐Ming Liu China 15 164 0.5× 113 0.5× 130 0.7× 111 1.0× 91 1.0× 50 563
Xiang Xie China 14 257 0.8× 166 0.8× 218 1.2× 97 0.9× 167 1.8× 40 720
L. Joost van Pelt Netherlands 12 142 0.5× 121 0.6× 66 0.4× 54 0.5× 97 1.1× 22 520
Taner Ulus Türkiye 17 337 1.1× 139 0.7× 70 0.4× 122 1.1× 131 1.4× 57 715
J. Ycas United States 11 550 1.8× 512 2.4× 157 0.9× 40 0.4× 112 1.2× 24 1.0k

Countries citing papers authored by Yared Gurmu

Since Specialization
Citations

This map shows the geographic impact of Yared Gurmu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yared Gurmu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yared Gurmu more than expected).

Fields of papers citing papers by Yared Gurmu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yared Gurmu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yared Gurmu. The network helps show where Yared Gurmu may publish in the future.

Co-authorship network of co-authors of Yared Gurmu

This figure shows the co-authorship network connecting the top 25 collaborators of Yared Gurmu. A scholar is included among the top collaborators of Yared Gurmu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yared Gurmu. Yared Gurmu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bergmark, Brian A., Deepak L. Bhatt, Philippe Gabríel Steg, et al.. (2021). Long‐Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS‐TIMI 54 Trial. Journal of the American Heart Association. 10(17). e020446–e020446. 10 indexed citations
2.
Berg, David D., Marc D. Samsky, Eric J. Velazquez, et al.. (2021). Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF Trial. Circulation Heart Failure. 14(2). e007034–e007034. 36 indexed citations
3.
Marston, Nicholas, Yared Gurmu, Giorgio Melloni, et al.. (2020). The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism. Circulation. 141(20). 1600–1607. 65 indexed citations
4.
Berg, David D., Eugene Braunwald, Adam D. DeVore, et al.. (2020). Efficacy and Safety of Sacubitril/Valsartan by Dose Level Achieved in the PIONEER-HF Trial. JACC Heart Failure. 8(10). 834–843. 21 indexed citations
5.
Gencer, Bariş, Xinmin S. Li, Yared Gurmu, et al.. (2020). Gut Microbiota‐Dependent Trimethylamine N‐oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS‐TIMI 54 Trial. Journal of the American Heart Association. 9(10). e015331–e015331. 33 indexed citations
6.
Furtado, Remo H.M., Ramkumar Venkateswaran, José Carlos Nicolau, et al.. (2020). Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS‐TIMI 54 Trial. Journal of the American Heart Association. 9(10). e015785–e015785. 6 indexed citations
7.
Bergmark, Brian A., David A. Morrow, Deepak L. Bhatt, et al.. (2019). NATRIURETIC PEPTIDES VERSUS A CLINICAL HISTORY OF HEART FAILURE FOR RISK PREDICTION IN PATIENTS WITH DIABETES. Journal of the American College of Cardiology. 73(9). 681–681. 1 indexed citations
8.
Bergmark, Brian A., Deepak L. Bhatt, Darren K. McGuire, et al.. (2019). Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction. Circulation. 140(12). 1004–1014. 66 indexed citations
9.
Marston, Nicholas, Frederick Kamanu, Francesco Nordio, et al.. (2019). Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score. Circulation. 141(8). 616–623. 128 indexed citations
10.
Berg, David D., Stephen D. Wiviott, Benjamin M. Scirica, et al.. (2019). Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus. Circulation. 140(19). 1569–1577. 89 indexed citations
11.
Morrow, David A., Eric J. Velazquez, Adam D. DeVore, et al.. (2019). Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial. European Heart Journal. 40(40). 3345–3352. 56 indexed citations
12.
Zelniker, Thomas A., David A. Morrow, Ofri Mosenzon, et al.. (2019). Cardiac and Inflammatory Biomarkers Are Associated with Worsening Renal Outcomes in Patients with Type 2 Diabetes Mellitus: Observations from SAVOR-TIMI 53. Clinical Chemistry. 65(6). 781–790. 8 indexed citations
13.
Bergmark, Brian A., Benjamin M. Scirica, Philippe Gabríel Steg, et al.. (2017). Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk. European Heart Journal. 39(24). 2255–2262. 44 indexed citations
14.
Bergmark, Brian A., Deepak L. Bhatt, Eugene Braunwald, et al.. (2017). Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease. Diabetes Care. 41(3). 577–585. 20 indexed citations
15.
Valeri, Linda, Oscar Patterson‐Lomba, Yared Gurmu, et al.. (2016). Predicting Subnational Ebola Virus Disease Epidemic Dynamics from Sociodemographic Indicators. PLoS ONE. 11(10). e0163544–e0163544. 14 indexed citations
16.
DiMeglio, Linda A., Jiajia Wang, George K. Siberry, et al.. (2012). Bone mineral density in children and adolescents with perinatal HIV infection. AIDS. 27(2). 211–220. 60 indexed citations
17.
Friedman, Kevin G., Joshua W. Salvin, David Wypij, et al.. (2011). Risk factors for failed staged palliation after bidirectional Glenn in infants, who have undergone stage one palliation☆. European Journal of Cardio-Thoracic Surgery. 40(4). 1000–6. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin J. Hirsh Breakdown of academic impact, for papers by Mireia Junyent Breakdown of academic impact, for papers by Srikanth Yandrapalli Breakdown of academic impact, for papers by Yaping Zhang Breakdown of academic impact, for papers by James Underberg Breakdown of academic impact, for papers by Pin‐Ming Liu Breakdown of academic impact, for papers by Xiang Xie Breakdown of academic impact, for papers by L. Joost van Pelt Breakdown of academic impact, for papers by Taner Ulus Breakdown of academic impact, for papers by J. Ycas
Rankless by CCL
2026